Reach out about this clinical trial
Contact Usor call 602-258-2863
CONDITION(S): Generalized Myasthenia Gravis Myasthenia gravis - TRIAL: Alexion gMG Registry ALXN-MG-501 - Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies.
Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies.